References
- Bock, M., Haberkorn, A., Herlinger, H., Mayer, K. H., & Petersen, S. (1972). The structure activity relationship of 4-(5’-nitrofurfurylidene-amino)-tetrahydro-4H-1,4-thiazine-1, 1-dioxides against Trypanosoma cruzi. Arzneimittel-Forschung, 22, 1564–1569.
- Bueding, E. (1972). Biochemical effects of antischistosomal drugs. In Comparative Biochemistry of Parasites, ed. Van den Bossche, H. pp. 25–32, New York: Academic Press.
- Bueding, E., Naguira, C., Bouwman, S. & Rose, G. (1971). The antischistosomal activity of a nitrovinylfuran derivative (SQ 18 506) in mice and hamsters. Journal of Pharmacology and Experimental Therapeutics, 178, 402–410.
- Freeman, F., Wilson, P. L. & Kazan, B. H. (1975). Trypanosoma cruzi: antimicrobial activity and strain differentiating properties of some five- and six-membered heterocyclic compounds on trypomastigotes. Experimental Parasitology, 38, 181–190.
- Gadebusch, H. H. & Basch, H. I. (1974). New antimicrobial nitrofuran, trans-5-amino-3-(2-(5-nitro-2-furyl)vinyl)-Δ2-1,2,4-oxadiazole: antibacterial, antifungal and antiprotozoal activities in vitro. Antimicrobial Agents and Chemotherapy, 6, 263–267.
- Garnham, P. C. C. (1956). Isolation of a new strain of Trypanosoma cruzi. Transactions of the Royal Society of Tropical Medicine and Hygiene, 50, 613.
- Gutteridge, W. E. (1976a). Experimental chemotherapy of Chagas’ disease. In New Approaches in American Trypanosomiasis Research, Pan American Health Organization Scientific Publication, No. 318, pp. 255–262.
- Gutteridge, W. E. (1976b). Chemotherapy of Chagas’ disease: the present situation. Tropical Diseases Bulletin, 73, 699–705.
- Gutteridge, W. E., Cover, B. & Gaborak, M. (1974). Activity of SQ 18 506 against Trypanosoma cruzi. Transactions of the Royal Society of Tropical Medicine and Hygiene, 68, 160–161,
- Gutteridge, W. E., Cover, B. & Gaborak, M. (1978). A/JAX inbred mice in chemotherapeutic investigations of experimental Chagas’ disease. Annals of Tropical Medicine and Parasitology, 72, 329–338.
- Gutteridge, W. E., Cover, B. & Gaborak, M. (1978). Isolation of blood and intracellular forms of Trypanosoma cruzi from rats and other rodents and preliminary studies of their metabolism. Parasitology, 76, 159–176.
- Gutteridge, W. E., Knowler, J. & Coombes, J. D. (1969). Growth of Trypanosoma cruzi in human heart tissue cells and effects of aminonucleoside of puromycin, trypacidin and aminopterin. Journal of Protozoology, 16, 521–525.
- Haberkorn, A. & Gönnert, R. (1972). Animal experimental investigation into the activity of Nifurtimox against Trypanosoma cruzi. Arzneimittel-Forschung, 22, 1570–1582.
- Jaffe, J. J. & Meymarian, E. (1973). Trypanocidal activity of a nitrovinylfuran derivative (SQ 18 506) in mice. Experimental Parasitology, 34, 242–250.
- McRipley, R. J., Gadebusch, H. H., Pansy, F. & Semar, R. (1974). New antimicrobial nitrofuran, trans-5-amino-3-(2-(5-nitro-2-furyl)vinyl)-Δ2-1,2,4-oxadiazole: antimicrobial efficacy in mice, rats and guinea pigs. Antimicrobial Agents and Chemotherapy, 6, 268–273.
- Pizzi, T. (1961). Un derivado imidazólico efectivo en el tratamiento de las infecciones experimentales por Trypanosoma cruzi. Boletin Chileno de Parasitologia, 16, 35–36.
- Richie, R. (1974). Chemotherapy of experimental acute Chagas’ disease in mice: parasitological cure by Ro 7–1051. Third International Congress of Parasitology, Proceedings, 3, 1296–1297.
- Shakin, M. M. & Kilbey, B. J. (1974). Genetic activity of the antischistosomal agent SQ 18 506 in yeast. Mutation Research, 26, 193–198.
- Velásquez-Antich, A. (1970). Efecto supresivo del ‘Ambilhar’, 1-(5-nitro-2-tiazolil)-2-imidazolidinona sôbre la infeccíon experimental del ratón por S. cruzi. I Consideraciones iniciales. Revista do Instituto de Medicina Tropical de São Paulo, 12, 347–353.